A Practitioner Statement on the Responsible Development of Ibogaine in the United States - Open Letter

Dear Colleagues,We write as a collective of practitioners, researchers, clinicians, and integration specialists with direct, long-term experience working with iboga and ibogaine across a range of settings. The growing interest in ibogaine within the United States — including public investment, emerging clinical pathways, and public-private partnerships — represents a meaningful shift in how this modality […]